Delivered-To: tjphuhs@gmail.com Received: by 2002:a5d:530e:0:b0:439:fcfb:30e with SMTP id e14csp103208wrv; Fri, 3 Apr 2026 15:08:01 -0700 (PDT) X-Received: by 2002:a05:622a:353:b0:50b:43b8:d5a5 with SMTP id d75a77b69052e-50d62a6e22emr76028781cf.39.1775254081610; Fri, 03 Apr 2026 15:08:01 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1775254081; cv=none; d=google.com; s=arc-20240605; b=AYu3BbArUEmKTD3mvi2jj3VuczyK/t8iuXAIwlNsT2b8C/o1pam71I2QMNcTrF+cJg TBx80NCwW5T/THYj4yynzCXP7DOaZzIudtpP5SIhQ3uhpsvclWKo+53JVmhSGgF/ua+d H+Vh0WWN+78N/FHszIxIGrHOLNTGkXgHqLLlW2bl6U/JgnH9jjGDEO94/uSy+5erhdd6 6m2yK0Rn2rVCfp7B4fk0AYo4MjDB79zq5W+FKJSUv3WWxICevnhIbEVZN9uDDwpacYrK GSRXL/cTXQ75TTjUDI4J/lg58fJKI7cXwXRIPWYWgM9fOfvdQk0R+nxuj2sgmddECt2V 5Kag== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=message-id:date:mime-version:sid:subject:reply-to :list-unsubscribe-post:list-unsubscribe:from:feedback-id:to :dkim-signature:dkim-signature; bh=P6cxFdSZD2xu2h2EZqmI8Raw6M1dsve85lqWX0x7ezs=; fh=Hcu5VqhndQNvtVhwbc8tr7JrSOSQJms/+lG2L+E9gBs=; b=gUlKMjlgtx6FD/omcVT/MXil16vv50rErXILunZ0yx4KBi5CcjhBAoP+QbdM1gT8iV gfZjJ6TYfrgIPTKaS9c2kxCM0A7drRIhllx2uM/AkMu41V1qAxpSeEqS/hvCGKncU27D 3UtVncMUAcIT60nA1FdmHcfj913MiMl2xIEFDewPN7DcEmKnjE7m/hqIfv8n3onMhtIo Okmqx3UrJnpvxWLRjDj9XWIVDyUbHyp91UIeAg/HginCZWdC4FbOxSIsgpwf/diHwMem qiMvLCF3L1lAxlAmU0JcCm9Pt1/m8qimIn/xfziKKayh2TLV1p8QEKmLA7OfR4OlgJ6R f9iA==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b="aR/RWHVM"; dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=Jp7o1S7K; spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.3 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com Return-Path: Received: from bh186-3.smtp-out.beehiivmail.net (bh186-3.smtp-out.beehiivmail.net. [69.67.186.3]) by mx.google.com with ESMTPS id d75a77b69052e-50d4b20992csi96001711cf.91.2026.04.03.15.08.01 for (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Fri, 03 Apr 2026 15:08:01 -0700 (PDT) Received-SPF: pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.3 as permitted sender) client-ip=69.67.186.3; Authentication-Results: mx.google.com; dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b="aR/RWHVM"; dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=Jp7o1S7K; spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.3 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com"; dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com X-BmtaRef: eyJfQF8iOiJcXF8vIiwicmVjaXBpZW50IjoidGpwaHVoc0BnbWFpbC5jb20iLCJ4X2xpc3RfaWQiOiJmZDQxNjMwZS1lOTFmLTQ2ZDktYTI3NC1iNzQwZGFiNzU2ZDIiLCJ4X3N1YnNjcmliZXJfaWQiOiI5YzQwZDYzOS02ZTFkLTQyOTItYTlkNy0wZTRjYmJiNWQ1ZGIifQ== DKIM-Signature: v=1; a=rsa-sha256; d=bhmta.beehiiv.com; s=bh; c=relaxed/relaxed; bh=P6cxFdSZD2xu2h2EZqmI8Raw6M1dsve85lqWX0x7ezs=; h=from:subject:mime-version:content-type:content-transfer-encoding: list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc: content-type:feedback-id:from:subject:to; t=1775254081; b=aR/RWHVMmu7gKrpD4VLbWWLfo4J/9uPbgUd+EuXoZlXKBmRQ0FpioyNiYm+nJBlbBR6hVIlCT 7Pi2VxsZMwUgYDh9r8VfBYHkiTsc/fNhvkPczuFs2TQnJv1Hz4+RSe2mB1rJSb2XmTUJ75TTAkJ dvOYGe5emqf9H7EtPYppoQuYAsG2q6zldFDap7i02/2jguepkyLOVSD/u8FIMxE23TmZClyGVtH NAIJSGyxwYMaH1s6BLn63bako6eqVcE+ktwiKfuMbRMLjr2l+cYHY5muatned/jT/ydda4BoamQ svLaFm4Jo+lVy691HR+PRQR7ooHdhqp5UjU8bTNgi87w==; DKIM-Signature: v=1; a=rsa-sha256; d=mail.beehiiv.com; s=bh; c=relaxed/relaxed; bh=P6cxFdSZD2xu2h2EZqmI8Raw6M1dsve85lqWX0x7ezs=; h=from:subject:mime-version:content-type:content-transfer-encoding: list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc: content-type:feedback-id:from:subject:to; t=1775254081; b=Jp7o1S7KMtg1tBFH+jhCDLb9+oj1F+swf3J9rLSAkciGQu0+jZ8Dy/PD5b050kkhK8gMiitTZ CCmlUGVtYzVV3B5jOm8Wr/LQl1+QE3JdsM14oQz3TFS+FtFDXXsOHI3cDmh7FdWV6RP5VPNeMY7 XBZYv2uEt/amytW0RxZtFjBsoY7I3LDIicd2sQ0a9bylxGRnLteilFjeYMTwKNBHt2uTpdXy4pr dAyxlSrhkIWNZ97lhEF/7txcaLTpk5H2JCGjgDEATBeJyEfdK8h7LKZ/VfM5pzytFzfISwr0/SJ R3cmh6jq493ylAYhyRR+enGtgU3Tk1rHYTjG6ycreOtQ==; Received: from mail.beehiiv.com by bhmta(mta28) with HTTP id <9492d4742fa911f185331214148f670d> for ; Fri, 03 Apr 2026 22:08:01 +0000 Content-Type: multipart/alternative; boundary="/gSoatXAT5yzRCGtbEl2xQ" To: "tjphuhs@gmail.com" Feedback-ID: 879926c4-80c7-4c67-a7d0-da881dbbeb3f:newsletter:fd41630e-e91f-46d9-a274-b740dab756d2:c8f61fda6a60803 From: Hunter Williams List-Unsubscribe: , List-Unsubscribe-Post: List-Unsubscribe=One-Click Reply-To: =?utf-8?Q?Hunter=27s_Health_Hacks?= Subject: Max Dose Tirzepatide, Retatrutide Horror Stories, BPC-157 Anhedonia, and More X-Batch-Id: 12285034-dc63-4aa1-b7d1-936cac32df0d X-Subscriber-ID: 9c40d639-6e1d-4292-a9d7-0e4cbbb5d5db sId: fd41630e-e91f-46d9-a274-b740dab756d2 x-beehiiv-ids: {"account_name":"https://huntershealthhacks.beehiiv.com/","campaign_id":"879926c4-80c7-4c67-a7d0-da881dbbeb3f","category":"newsletter","email_generated_at":1775254079,"user_id":"fd41630e-e91f-46d9-a274-b740dab756d2"} x-beehiiv-type: newsletter x-list-id: fd41630e-e91f-46d9-a274-b740dab756d2 x-list-owner: x-newsletter: https://huntershealthhacks.beehiiv.com/p/max-dose-tirzepatide-retatrutide-horror-stories-bpc-157-anhedonia-and-more x-newsletter-id: https://huntershealthhacks.beehiiv.com/ x-newsletter-signup: https://huntershealthhacks.beehiiv.com/subscribe Mime-Version: 1.0 Date: Fri, 3 Apr 2026 22:08:01 +0000 Message-ID: <20260403.220801.25f68aa3@mta28> --/gSoatXAT5yzRCGtbEl2xQ Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Happy Friday and Happy Easter weekend to those of you celebrating! =0A=0AI = just published the March 2026 Q&A episode.=0A=0AThe podcast is now live on = both [YouTube](https://www.youtube.com/watch?v=3D4igc2UpFr7Q) and [Spotify]= (https://open.spotify.com/episode/7Hp4gx4DNSSmXJAM8kliDO?si=3D1rcXny45TrapP= zZsuSC2QA). If you haven't subscribed on both platforms yet, please do that= . It helps more than you know. =0A=0A=E2=80=9CIf you haven't filled out our= crowdsourced safety data survey on BPC-157 at the Peptide Safety Initiativ= e, please take a few minutes to do so. This is a community-driven project, = and every response matters. You can find it at [peptidesafetyinitiative.com= /bpc-157](https://peptidesafetyinitiative.com/bpc-157).=E2=80=9C =E2=80=94 = =0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=0A=0A**Here's a taste of what we got into on this = one:**=0A=0A* Staying on max dose tirzepatide (15mg) and still not at goal = weight. What to do next and how to transition to retatrutide if needed.=0A= =0A* Why getting hormonally optimized might actually let you get better res= ults at a LOWER GLP-1 dose.=0A=0A* Dealing with brutal GI side effects on r= etatrutide. Burping, dry heaving, food sitting in your stomach. What actual= ly helps.=0A=0A* Why restarting a GLP-1 at the same dose can hit harder the= second time around. GLP-1 receptor upregulation is real.=0A=0A* Using tirz= epatide and cagrilintide together. Yes, I've seen this combo work.=0A=0A* T= he glucagon component of retatrutide and why it can raise A1C in some peopl= e. This one surprises a lot of folks.=0A=0A* Why combining tirzepatide and = retatrutide is NOT dangerous despite what some influencers are claiming for= clicks.=0A=0A* GLP-1 non-responders. They exist. Potential genetic phenoty= pes and what else you can try.=0A=0A* The full muscle-building stack alongs= ide GLP-1s. HRT, growth hormone peptides, growth factors, myostatin inhibit= ors, metabolic modulators, and injectable oxytocin.=0A=0A* Tesamorelin refr= igeration drama. My personal experience, the MOTS-C stability study, and wh= y this debate generates more engagement than answers.=0A=0A* Ipamorelin and= the ghrelin question. Why it won't mess with your fat loss goals the way M= K-677 or GHRP-6 might.=0A=0A* HGH for women 55+ vs. secretagogues. =0A=0A* = BPC-157 and anhedonia, especially when combined with Wellbutrin. The dopami= ne connection and what to use instead.=0A=0A* Pre and post surgery peptide = protocol.=0A=0A* MOTS-C making people MORE tired instead of energized. Why = reactive oxygen species buildup could be the culprit.=0A=0A* Peptides for s= ocial anxiety, confidence, and fear. Dihexa, Noopept, oxytocin, and why the= chemical piece is only part of the equation.=0A=0A* Urolithin A and spermi= dine dosing for mitophagy and autophagy. Two of my favorite background play= ers.=0A=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94= =E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2= =80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80= =94=E2=80=94=E2=80=94=E2=80=94=0A=0A**Final Thoughts**=0A=0ATo close this o= ut on a personal note, Happy Easter weekend! =0A=0AFrom the bottom of my he= art, thank you. Whatever shape, form, or fashion connects us, just know I'm= grateful for it. Getting to do this is a dream come true for me. And I hop= e you feel that comes through in the content.=0A=0AWhether it's subscribing= , sharing with a friend, joining the email list, being part of the Axion Co= llective, or using my codes, all of it goes a long way toward helping me ke= ep bringing you these messages.=0A=0ABest,=0A=0AHunter Williams =0A=0A**P.S= .** Submit your questions for next month's Q&A using [this link](https://hu= nterwilliamsvideotopic.carrd.co/). And if you want guaranteed answers plus = direct access to me, the [Axion Collective](https://theaxioncollective.manu= s.space/) has live coaching calls every Thursday at 8 PM Eastern.=0A=0A=0A= =E2=80=94=E2=80=94=E2=80=94=0A=0AYou are reading a plain text version of th= is post. For the best experience, copy and paste this link in your browser = to view the post online:=0Ahttps://huntershealthhacks.beehiiv.com/p/max-dos= e-tirzepatide-retatrutide-horror-stories-bpc-157-anhedonia-and-more --/gSoatXAT5yzRCGtbEl2xQ Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Max Dose Tirzepatide, Retatrutide Horror Stories, BPC-157 Anhedonia, and = More
March 2026 Q&A Video is Live!  ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌ ‌ ̴= 4; ‌ ‌ ‌ ‌ ‌ &#= 8204; ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌&#= 160;‌ ‌ ‌ ‌ ‌ ‌= ; ‌ ‌ ‌ ‌ ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌ ‌ ̴= 4; ‌ ‌ ‌ ‌ ‌ &#= 8204; ‌ ‌ ‌ ‌ ‌ = ;‌ ‌ ‌ ‌ ‌ ‌&#= 160;‌ ‌ ‌ ‌ ‌ ‌= ; ‌ ‌ ‌ ‌ ‌ = 204; ‌ ‌ ‌ ‌ ‌ = ‌ ‌ ‌ ‌ ‌ ‌= 60;‌ ‌ ‌ ‌ ‌ ‌=  ‌ ‌ ‌ ‌ ‌ R= 04; ‌ ‌ ‌ ‌ ‌ &= #8204; ‌ ‌ ‌ ‌ ‌= 0;‌ ‌ ‌ ‌ ‌ ‌&= #160;‌ ‌ ‌ ‌ ‌ ̴= 4; ‌ ‌
=
= <= td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo= rd-break:break-word;">

Whether it's subscribing, sharing with a friend,= joining the email list, being part of the Axion Collective, or using my co= des, all of it goes a long way toward helping me keep bringing you these me= ssages.

<= td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo= rd-break:break-word;">

P.S.= Submit your questions for next month's Q&A using this link. And if you want guaranteed answers pl= us direct access to me, the Axion Collective has live coaching calls every Thursday at 8 PM Eastern.

=

April 03, 2026   |   Read online

= Max Dose Tirzepatide, Retatrutide Horror Stories, BPC-157 Anhedonia, and M= ore

March 2026 Q&A Video is Live!

 = <= /tr>
3D"share
 
3D"share
 
=3D"share
3D""

Happy Friday and Happy Easter weekend to those = of you celebrating!

I just = published the March 2026 Q&A episode.

The podcast is now live on both YouTube and Spotify. If you haven't subscribed on both platforms yet, please do th= at. It helps more than you know.

If you haven't filled out our crowdsourced safety data survey on BPC-= 157 at the Peptide Safety Initiative, please take a few minutes to do so. T= his is a community-driven project, and every response matters. You can find= it at p= eptidesafetyinitiative.com/bpc-157.

=
 

H= ere's a taste of what we got into on this one:

    =

  • Staying on max dose tirzepatide (15mg) and still not at goal weight. W= hat to do next and how to transition to retatrutide if needed.

  • Why getting hormonally optimized might actually let you get better = results at a LOWER GLP-1 dose.

  • Dealing with brutal GI s= ide effects on retatrutide. Burping, dry heaving, food sitting in your stom= ach. What actually helps.

  • Why restarting a GLP-1 at the= same dose can hit harder the second time around. GLP-1 receptor upregulati= on is real.

  • Using tirzepatide and cagrilintide together= . Yes, I've seen this combo work.

  • The glucagon comp= onent of retatrutide and why it can raise A1C in some people. This one surp= rises a lot of folks.

  • Why combining tirzepatide and ret= atrutide is NOT dangerous despite what some influencers are claiming for cl= icks.

  • GLP-1 non-responders. They exist. Potential genet= ic phenotypes and what else you can try.

  • The full muscl= e-building stack alongside GLP-1s. HRT, growth hormone peptides, growth fac= tors, myostatin inhibitors, metabolic modulators, and injectable oxytocin.<= /span>

  • Tesamorelin refrigeration drama. My personal experience= , the MOTS-C stability study, and why this debate generates more engagement= than answers.

  • Ipamorelin and the ghrelin question. Why= it won't mess with your fat loss goals the way MK-677 or GHRP-6 might.=

  • HGH for women 55+ vs. secretagogues.

  • BPC-157 and anhedonia, especially when combined with Wellbutrin. The = dopamine connection and what to use instead.

  • Pre and po= st surgery peptide protocol.

  • <= p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-brea= k:break-word;">MOTS-C making people MORE = tired instead of energized. Why reactive oxygen species buildup could be th= e culprit.

  • Peptides for social anxiety, confidence, and= fear. Dihexa, Noopept, oxytocin, and why the chemical piece is only part o= f the equation.

  • Urolithin A and spermidine dosing for m= itophagy and autophagy. Two of my favorite background players.

 

Final Thoughts

To close this out on a personal note, Happy Easter weeken= d!

From the bottom of my he= art, thank you. Whatever shape, form, or fashion connects us, just know I&#= 39;m grateful for it. Getting to do this is a dream come true for me. And I= hope you feel that comes through in the content.

Best,

<= span style=3D"font-size:1.5rem;">Hunter Williams

<= /tr>
3D"ig"3D"yt"
<= /td>
3D""

Want more? Here=E2=80=99s how you can work with me:

<= /tr>

=F0=9F=91=89Jo= in my private coaching group, The AXION Collective:

=F0=9F=91=89Try Zeroats, the world=E2=80=99s first sugar-free, na= turally flavored oatmeal:

<= /div>

=F0=9F=91=89Link To All My Old Videos:

=F0=9F=91=89Audio Versions of All Videos:

=F0=9F=91=89Get the P= eptide Cheat Sheet:

=F0=9F=91=89All my daily essen= tials on Amazon

=F0=9F=91=89Get discounts o= n your favorite peptides and research chemicals:

<= td style=3D"padding-bottom:12px;padding-left:37px;padding-right:27px;paddin= g-top:12px;" class=3D"ee">

=F0=9F=91=8910% off the BEST = workout supplements from Unmatched Supps (pre-workout, whey protein, creati= ne, EAAs, electrolytes - use code HUNTERW at checkout):

=F0=9F=91=89Submi= t A Video Topic For My Next YouTube Video:

=

Update your email = preferences or unsubscribe here

© 2026 Hunt= er's Health Hacks

228 Park Ave S, #29976, New York, New York 10= 003, United States

Powered by beehiiv
Terms of Service
<= /body> --/gSoatXAT5yzRCGtbEl2xQ--